Loss of MiR-155 Sensitizes FLT3-ITD+AML to Chemotherapy and FLT3 Inhibitors via Glycolysis Blocking by Targeting PIK3R1. The gene discussed is PIK3R1; the disease is acute myeloid leukemia.